Three interest rate rises are now on the table according to some economists, and I think that call is wrong, and dangerous for the economy. Here's why I'm sitting on cash until the picture clears.
A 25-year record of rising dividends and market-beating returns makes Washington H. Soul Pattinson a company worth considering – but after a strong rally since…
This week's Hot Stock is James Hardie Industries, with Morgans' Raymond Chan explaining why his research team has upgraded JHX to Accumulate following the company's…
Getting drugs past the brain's own security system is one of biotech's toughest problems. I've found four ASX-listed companies – Telix, Noxopharm, Neurizon and Ceretas…
Let's run through the week's ratings changes from the seven brokers monitored daily by FNArena, including a swathe of upgrades led by Lovisa Holdings, a…
The latest from the studio here at Switzer, from podcasts with industry leaders through to weekly check-ins with market experts and even a subscriber-exclusive livestream.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
